BioCentury
ARTICLE | Company News

Auvation Ltd., EiRx deal

August 15, 2005 7:00 AM UTC

Apoptosis company ERX acquired the 5% of Auvation it did not already own from an affiliate of Merck KGaA (Darmstadt, Germany) for 2.3 million ERX shares in July. In May, ERX increased its holding in ...